Kirkland & Ellis advised Blackstone on the transaction, and Goodwin Procter advised TA Associates, alongside Fortissimo. Blackstone announced that Blackstone Growth and affiliated funds (collectively “Blackstone”)...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Advanced Biologics in its merger with Isto Biologics. Isto Biologics, a portfolio company of TSCP and a global leader in regenerative and autologous...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Unanet and JMI Equity on the deal, while Latham & Watkins represented Onex. Unanet announced a new round of strategic financing from Onex Corporation...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised the underwriters on the deal while Goodwin Procter represented Amylyx Pharmaceuticals. Amylyx Pharmaceuticals, Inc. (“Amylyx”), a clinical-stage pharmaceutical company...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised AbCellera on the deal. AbCellera (Nasdaq: ABCL) announced its acquisition of TetraGenetics. AbCellera is a technology company with a centralized operating system for next-generation...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Pear Therapeutics on the deal. Pear Therapeutics announced its definitive business combination agreement with Thimble Point Acquisition Corp. (Nasdaq: THMA), a special purpose...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised One GI on the deal. One GI announced its acquisition of Gastroenterology Health Partners, PLLC (GHP). The deal marks One GI’s sixth acquisition...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised One GI on the deal. One GI announced its acquisition of Gastroenterology Health Partners, PLLC (GHP). The deal marks One GI’s sixth acquisition...
You must be a Standard 1 Year member to access this content.
